MARKET

CBLI

CBLI

Cleveland Biolbs
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5500
+0.0310
+5.98%
Opening 14:10 11/19 EST
OPEN
0.5449
PREV CLOSE
0.5190
HIGH
0.5500
LOW
0.5449
VOLUME
1.54K
TURNOVER
--
52 WEEK HIGH
2.160
52 WEEK LOW
0.5000
MARKET CAP
6.21M
P/E (TTM)
-2.0538
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CBLI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

CBLI News

  • The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout
  • Benzinga.6h ago
  • What Kind Of Investor Owns Most Of Cleveland BioLabs, Inc. (NASDAQ:CBLI)?
  • Simply Wall St..1d ago
  • The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
  • Benzinga.4d ago
  • Cleveland BioLabs Q3 EPS $(0.04) Up From $(0.1) YoY
  • Benzinga.4d ago

More

Industry

Biotechnology & Medical Research
+2.10%
Pharmaceuticals & Medical Research
+0.74%

Hot Stocks

Name
Price
%Change

About CBLI

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is Entolimod, an immuno-stimulatory agent, which it is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. Its other products include CBLB612, Mobilan and CBL0137. CBLB612 is a compound based upon a natural activator of another tissue-specific component of the innate immune system, the toll-like receptor 2 (TLR2)/ toll-like receptor 6 (TLR6) heterodimeric receptor. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand. CBL0137 is a small molecule with a multi-targeted mechanism of action that may be useful for the treatment of various types of cancer.
More

Webull offers Cleveland BioLabs, Inc. (CBLI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.